Coaching Opioid Treatment Programs to Offer On-Site HIV and Hepatitis C Testing
Tests coaching programs helping opioid treatment clinics offer HIV testing to adults in treatment.
Plain-language title generated from the registry record
Registry title: Project I Test: Implementing HIV Testing in Opioid Treatment Programs
Key facts
- Where
- New York, United StatesSee the site
AI summary: who the study is looking for
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for opioid treatment programs (clinics), not individual patients. It tests coaching to help these clinics offer on-site HIV testing, and HIV and hepatitis C testing, with linkage to care.
- Age
- The record gives a minimum age of 18 years.
- Sex
- All sexes can join.
Main reasons for not taking part
- Clinics where over 50% of patients served in the prior 6 months were tested for HIV or HCV
- Clinics that see fewer than 150 unduplicated patients per year
- Clinics that cannot or will not collect the required testing and patient data
- Clinics whose key staff will not take part in surveys, interviews and coaching
- Clinics terminated by decision of the principal investigator
Read by machine on 12 November 2026.
Where in United States
- Columbia University Medical CenterNew York, United StatesContact: Lauren Gooden, PhDTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorTrial details
- Who runs it
- Columbia University
- Trial code
- NCT03135886
- Record updated
- 7 August 2026
- Original description
This study will test two active evidence-based "practice coaching" (PC) interventions to improve opioid treatment programs' (OTPs') provision and sustained implementation of on-site 1) HIV testing and linkage to care and 2) HIV/Hepatitis C virus (HCV) testing and linkage to care among patients seeking/receiving substance use disorder treatment.Read full original descriptionShow less
A Cluster RCT to Increase HIV Testing in Substance Use Treatment Programs
This study will test two active evidence-based "practice coaching" (PC) interventions to improve opioid treatment programs' (OTPs') provision and sustained implementation of on-site 1) HIV testing and linkage to care and 2) HIV/Hepatitis C virus (HCV) testing and linkage to care among patients seeking/receiving substance use disorder treatment.
Aims are:
Aim 1: To evaluate the effectiveness of the PC interventions on improving patient uptake of HIV testing in OTPs including the incremental impact of the HIV/HCV intervention on HIV testing.
Aim 2: To examine, using mixed-methods, the impact of the PC interventions on the initiation and sustained provision of HIV testing and timely linkage to care.
Aim 3: To evaluate the health outcomes, health care utilization, and cost-effectiveness of the PC interventions compared incrementally to one another and to the control condition.
Primary Hypothesis:
1. The two PC interventions will result in significantly higher proportions of patients tested for HIV than the information control condition during the "initial impact" period (7-12 months post-randomization or T3), controlling for the proportion of patients tested during the baseline period, T1 (Primary) and during the "sustained impact" period, 13-18 months post-randomization or T4 (Secondary). 2. The HIV/HCV PC intervention will result in significantly higher proportions of patients tested for HIV than the HIV PC intervention during the initial impact period (7-12 months post-randomization or T3), controlling for the proportion of patients tested during the baseline period, T1 (Secondary) and during the "sustained impact" period, 13-18 months post-randomization or T4 (Secondary).
Inclusion: Eligible sites must:; See at least 150 unduplicated patients/year/site; Be capable and willing to prospectively collect data on the number of patients who a) are offered any HIV and/or HCV tests; b) completed these tests; c) are referred to care/evaluation (and type of referral) if positive; and d) are linked to care/evaluation within 30 days of diagnosis; Be capable and willing to provide patient demographics, testing data within demographic categories of gender and race/ethnicity (in aggregate) and data on HIV/HCV test reimbursement processes and outcomes; Have key staff willing to consent to participate in study surveys, qualitative interviews and intervention coaching throughout the study.
Exclusion: Sites will be excluded if:; Over 50% of patients served in the prior 6 months were HIV or HCV tested; They are terminated via PI decision/discretion.